IMU 1.82% 5.6¢ imugene limited

Ann: Imugene Corporate Presentation, page-41

  1. 216 Posts.
    lightbulb Created with Sketch. 19
    Hi Bava, I do enjoy your thread. I know B Cell have been disprioritised for other 3 platforms with clinic trials. While we do expect a license out for HER-vaxx which was on previous presentation that business development discussion are undergoing for HER-Vaxx. if they put value of B cell as zero right now, the current SP makes sense at all phase 1 trial without significant data yet announced. All are speculations from here.
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
5.6¢
Change
0.001(1.82%)
Mkt cap ! $411.5M
Open High Low Value Volume
5.5¢ 5.7¢ 5.3¢ $731.7K 13.32M

Buyers (Bids)

No. Vol. Price($)
5 580359 5.6¢
 

Sellers (Offers)

Price($) Vol. No.
5.7¢ 686331 5
View Market Depth
Last trade - 16.10pm 18/07/2024 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.